itemprop=description content=A study in the journal Vaccine reveals that misinformation and concerns about side effects are leading reasons why over 80% of eligible Americans have skipped the SARS-CoV-2 vaccine booster. The research underscores the need for more public education about the vaccine's benefits in combating severe COVID-19 infections.
By Hugo Francisco de SouzaOct 5 2023Reviewed by Susha Cheriyedath, M.Sc. In a recent study published in the journal Vaccine, researchers investigated why more than 80% of eligible Americans have not taken their severe acute respiratory syndrome coronavirus 2 vaccine booster dose. They conducted an online survey of 2,298 respondents to evaluate the reasons underlying the low observed response.
A background on COVID-19 and vaccination drives The ongoing coronavirus disease of 2019 pandemic remains one of the worst in recorded history, with the World Health Organization COVID-19 dashboard reporting almost 771 million confirmed cases and almost 7 million deaths worldwide.
To address this need, Pfizer and Moderna developed updated mRNA vaccines designed to perform against both ancestral and Omicron SAR-CoV-2 strains, which the US Food and Drug Administration approved for emergency authorization use and the Centres for Disease Control and Prevention subsequently recommended for public consumption.
Related StoriesData collection involved recording demographic- and COVID-19-associated details, especially pre-existing health conditions, severity and symptoms of SARS-CoV-2 infection, COVID-19 test results, and health behaviors. The REDCap was used for survey design and administration. As and when required, additional COVID-19-specific research questionnaires were emailed to the relevant survey respondents.
Study findings Of the 4,827 individuals contacted, 2,298 completed all survey rounds, 2,196 of whom had received at least one vaccination dose and were hence included in statistical analyses. Participants who completed the survey were on average, older than those who did not , with all other demographic characteristics remaining statistically equal.
“The frequency of the remaining responses, in order of most-to-least reported, were as follows: I’m worried about side effects ; I don’t think this booster will add more protection over the vaccines I’ve already had ; I’m worried about the safety of the booster ; I don’t think the booster will protect me from infection ; I don’t think the booster will protect me from severe disease or death ; I didn’t know I was eligible to receive it ; I didn’t know it was available ; I don’t have time to get...
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Two thirds of Brits don't know who can get an autumn COVID booster vaccineAs autumn boosters are being rolled out for at-risk groups and the elderly, exclusive polling reveals that most people are unaware who can get one, while younger people are more concerned about the disease and are still taking many precautions.
Read more »
Two thirds of Brits don't know who precisely can get an autumn COVID booster vaccineAs autumn boosters are being rolled out for at-risk groups and the elderly, exclusive polling reveals that most people are unaware who can get one, while younger people are more concerned about the disease and are still taking many precautions.
Read more »
FDA approves updated Novavax COVID vaccineFederal regulators on Tuesday gave the go-ahead to an updated Novavax COVID vaccine, giving Americans a more traditional alternative to two recently revamped mRNA vaccines.
Read more »
In early trial, promising results for Moderna's combo COVID-flu vaccineModerna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19.
Read more »
Does COVID-19 or COVID-19 vaccination worsen migraines?Research published in the European Journal of Neurology indicates that COVID-19 and COVID-19 vaccination have negligible effects on migraine severity.
Read more »
Trump kicked off Forbes 400 richest Americans list amid fraud trial'Donald Trump is no longer rich enough for the country’s most exclusive club,' stated Forbes.
Read more »